Lv1
40 积分 2022-08-10 加入
Abstract P2-01-01: Interim analysis (n=200) from ELEANOR: a multi-national, prospective, non-interventional study among patients with HER2+ and HR+ early breast cancer treated with extended adjuvant neratinib in the clinical routine
2个月前
已完结
Deciphering breast cancer: from biology to the clinic
1年前
已完结
人表皮生长因子受体2阳性乳腺癌临床诊疗专家共识（2021版）
1年前
已完结
Effect of smoking habits on the efficacy of EGFR-TKI plus anti-angiogenic agent in advanced EGFR-mutant NSCLC
2年前
已完结
皖公网安备34019202002308
